$BLSI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALSERES PHARMACEUTICALS INC /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALSERES PHARMACEUTICALS INC /DE. Get notifications about new insider transactions in ALSERES PHARMACEUTICALS INC /DE for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 27 2011 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Sell | D | 0.00 | 2,331,034 | 5,828 | 15,376,004 | 17.7 M to 15.4 M (-13.16 %) |
Dec 27 2011 | BLSI | ALSERES PHARMACEUT ... | Gipson Thomas Livingston | 10% Owner | Sell | D | 0.00 | 537,931 | 1,345 | 45,604 | 583.5 K to 45.6 K (-92.18 %) |
Dec 22 2011 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Option Exercise | C | 2.50 | 5,827,585 | 14,568,963 | 7,172,415 | |
Dec 22 2011 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Buy | M | 2.50 | 2,331,034 | 5,827,585 | 17,707,038 | 15.4 M to 17.7 M (+15.16 %) |
Dec 22 2011 | BLSI | ALSERES PHARMACEUT ... | Gipson Thomas Livingston | 10% Owner | Option Exercise | C | 2.50 | 1,344,828 | 3,362,070 | 1,655,173 | |
Dec 22 2011 | BLSI | ALSERES PHARMACEUT ... | Gipson Thomas Livingston | 10% Owner | Buy | M | 2.50 | 537,931 | 1,344,828 | 5,193,935 | 4.7 M to 5.2 M (+11.55 %) |
Dec 20 2011 | BLSI | ALSERES PHARMACEUT ... | Gipson Thomas Livingston | 10% Owner | Sell | D | 0.01 | 530,000 | 5,300 | 5,656,004 | 6.2 M to 5.7 M (-8.57 %) |
Dec 20 2011 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Option Exercise | C | 25.00 | 184,000 | 4,600,000 | 12,000 | |
Dec 20 2011 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Sell | C | 0.00 | 4,600,000 | 0 | 15,436,004 | 20 M to 15.4 M (-22.96 %) |
Dec 20 2011 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Sell | D | 0.01 | 60,000 | 600 | 15,376,004 | 15.4 M to 15.4 M (-0.39 %) |
Jan 03 2011 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Sell | D | 0.03 | 270,000 | 8,100 | 6,836,004 | 7.1 M to 6.8 M (-3.80 %) |
Apr 23 2009 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Option Exercise | P | 1.00 | 20,000 | 20,000 | 60,000 | |
Apr 23 2009 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Option Exercise | P | 1.00 | 20,000 | 20,000 | 40,000 | |
Apr 23 2009 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Option Exercise | P | 1.00 | 20,000 | 20,000 | 20,000 | |
Apr 23 2009 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Option Exercise | P | 2.50 | 5,000,000 | 12,500,000 | 13,000,000 | |
Apr 23 2009 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Option Exercise | P | 2.50 | 3,000,000 | 7,500,000 | 8,000,000 | |
Apr 23 2009 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Buy | P | 0.69 | 1,456,522 | 1,000,631 | 7,106,004 | 5.6 M to 7.1 M (+25.78 %) |
Apr 23 2009 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Buy | P | 1.84 | 543,478 | 1,000,000 | 5,649,482 | 5.1 M to 5.6 M (+10.64 %) |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | LANGER ROBERT | Director | Option Exercise | A | 1.15 | 25,000 | 28,750 | 25,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | Mullen Michael James | Director | Option Exercise | A | 1.15 | 25,000 | 28,750 | 25,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | PRESTON JOHN T | Director | Option Exercise | A | 1.15 | 25,000 | 28,750 | 25,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | GUINNESS WILLIAM | Director | Option Exercise | A | 1.15 | 25,000 | 28,750 | 25,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | SAVAS PETER G | Chief Executive Off ... | Option Exercise | A | 1.15 | 950,000 | 1,092,500 | 950,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | SAVAS PETER G | Chief Executive Off ... | Option Exercise | D | 2.87 | 200,000 | 574,000 | 200,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | SAVAS PETER G | Chief Executive Off ... | Option Exercise | D | 2.50 | 350,000 | 875,000 | 350,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | SAVAS PETER G | Chief Executive Off ... | Option Exercise | D | 3.75 | 400,000 | 1,500,000 | 400,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | Brem Henry | Director | Option Exercise | A | 1.15 | 25,000 | 28,750 | 25,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | FRASHIER GARY E | Director | Option Exercise | A | 1.15 | 25,000 | 28,750 | 25,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | PYKETT MARK JEROME | President and COO | Option Exercise | A | 1.15 | 425,000 | 488,750 | 425,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | PYKETT MARK JEROME | President and COO | Option Exercise | D | 2.87 | 100,000 | 287,000 | 100,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | PYKETT MARK JEROME | President and COO | Option Exercise | D | 2.50 | 225,000 | 562,500 | 225,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | PYKETT MARK JEROME | President and COO | Option Exercise | D | 3.75 | 100,000 | 375,000 | 100,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | RICE KENNETH L JR | Exec VP of Fin & Ad ... | Option Exercise | A | 1.15 | 375,000 | 431,250 | 375,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | RICE KENNETH L JR | Exec VP of Fin & Ad ... | Option Exercise | D | 2.87 | 100,000 | 287,000 | 100,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | RICE KENNETH L JR | Exec VP of Fin & Ad ... | Option Exercise | D | 2.50 | 225,000 | 562,500 | 225,000 | |
Jan 16 2009 | BLSI | ALSERES PHARMACEUT ... | RICE KENNETH L JR | Exec VP of Fin & Ad ... | Option Exercise | D | 3.25 | 300,000 | 975,000 | 300,000 | |
Jan 03 2008 | BLSI | ALSERES PHARMACEUT ... | Bobe Frank | Chief Business Offi ... | Grant | A | 0.00 | 3,363 | 0 | 3,363 | 0 to 3.4 K |
Jan 03 2008 | BLSI | ALSERES PHARMACEUT ... | PYKETT MARK JEROME | President & COO | Grant | A | 0.00 | 6,777 | 0 | 6,777 | 0 to 6.8 K |
Jan 03 2008 | BLSI | ALSERES PHARMACEUT ... | RICE KENNETH L JR | EXEC VP OF FIN & AD ... | Grant | A | 0.00 | 4,485 | 0 | 4,485 | 0 to 4.5 K |
Jan 03 2008 | BLSI | ALSERES PHARMACEUT ... | SAVAS PETER G | Chief Executive Off ... | Grant | A | 0.00 | 11,212 | 0 | 11,212 | 0 to 11.2 K |
Dec 07 2007 | BLSI | ALSERES PHARMACEUT ... | PRESTON JOHN T | Director | Option Exercise | A | 3.10 | 25,000 | 77,500 | 100,417 | |
Dec 07 2007 | BLSI | ALSERES PHARMACEUT ... | LANGER ROBERT | Director | Option Exercise | A | 3.10 | 25,000 | 77,500 | 137,103 | |
Dec 07 2007 | BLSI | ALSERES PHARMACEUT ... | Mullen Michael James | Director | Option Exercise | A | 3.10 | 25,000 | 77,500 | 100,417 | |
Dec 07 2007 | BLSI | ALSERES PHARMACEUT ... | GUINNESS WILLIAM | Director | Option Exercise | A | 3.10 | 25,000 | 77,500 | 55,000 | |
Dec 07 2007 | BLSI | ALSERES PHARMACEUT ... | FRASHIER GARY E | Director | Option Exercise | A | 3.10 | 20,000 | 62,000 | 45,000 | |
Dec 07 2007 | BLSI | ALSERES PHARMACEUT ... | Brem Henry | Director | Option Exercise | A | 3.10 | 20,000 | 62,000 | 45,000 | |
Apr 17 2007 | BLSI | ALSERES PHARMACEUT ... | Bobe Frank | Chief Business Offi ... | Option Exercise | A | 2.94 | 300,000 | 882,000 | 300,000 | |
Jun 12 2007 | BLSI | ALSERES PHARMACEUT ... | Gipson Thomas Livingston | 10% Owner | Buy | C | 2.50 | 2,000,000 | 5,000,000 | 4,986,004 | 3 M to 5 M (+66.98 %) |
Jun 12 2007 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Buy | C | 2.50 | 2,000,000 | 5,000,000 | 5,106,004 | 3.1 M to 5.1 M (+64.39 %) |
Jun 08 2007 | BLSI | ALSERES PHARMACEUT ... | SAVAS PETER G | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 2.87 | 200,000 | 574,000 | 1,150,000 | |
Jun 08 2007 | BLSI | ALSERES PHARMACEUT ... | RICE KENNETH L JR | EXEC VP OF FIN & AD ... | Option Exercise | A | 2.87 | 100,000 | 287,000 | 625,000 | |
Jun 08 2007 | BLSI | ALSERES PHARMACEUT ... | PYKETT MARK JEROME | President & COO | Option Exercise | A | 2.87 | 100,000 | 287,000 | 625,000 | |
Mar 20 2007 | BLSI | ALSERES PHARMACEUT ... | FRASHIER GARY E | Director | Option Exercise | A | 2.49 | 10,000 | 24,900 | 25,000 | |
Mar 20 2007 | BLSI | ALSERES PHARMACEUT ... | GUINNESS WILLIAM | Director | Option Exercise | A | 2.49 | 15,000 | 37,350 | 30,000 | |
Mar 20 2007 | BLSI | ALSERES PHARMACEUT ... | Brem Henry | Director | Option Exercise | A | 2.49 | 10,000 | 24,900 | 25,000 | |
Mar 20 2007 | BLSI | ALSERES PHARMACEUT ... | Mullen Michael James | Director | Option Exercise | A | 2.49 | 15,000 | 37,350 | 75,417 | |
Mar 20 2007 | BLSI | ALSERES PHARMACEUT ... | LANGER ROBERT | Director | Option Exercise | A | 2.49 | 15,000 | 37,350 | 112,103 | |
Mar 20 2007 | BLSI | ALSERES PHARMACEUT ... | PRESTON JOHN T | Director | Option Exercise | A | 2.49 | 15,000 | 37,350 | 75,417 | |
Feb 07 2007 | BLSI | ALSERES PHARMACEUT ... | FRASHIER GARY E | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Feb 07 2007 | BLSI | ALSERES PHARMACEUT ... | Brem Henry | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Dec 18 2006 | BLSI | ALSERES PHARMACEUT ... | PRESTON JOHN T | Director | Option Exercise | A | 2.49 | 10,000 | 24,900 | 60,417 | |
Dec 18 2006 | BLSI | ALSERES PHARMACEUT ... | LANGER ROBERT | Director | Option Exercise | A | 2.49 | 10,000 | 24,900 | 97,103 | |
Dec 18 2006 | BLSI | ALSERES PHARMACEUT ... | Mullen Michael James | Director | Option Exercise | A | 2.49 | 10,000 | 24,900 | 60,417 | |
Jul 27 2006 | BLSI | ALSERES PHARMACEUT ... | GUINNESS WILLIAM | Director | Option Exercise | A | 3.80 | 15,000 | 57,000 | 15,000 | |
Jan 10 2006 | BLSI | ALSERES PHARMACEUT ... | SAVAS PETER G | Chief Executive Off ... | Option Exercise | A | 2.50 | 350,000 | 875,000 | 950,000 | |
Jan 10 2006 | BLSI | ALSERES PHARMACEUT ... | PYKETT MARK JEROME | President and COO | Option Exercise | A | 2.50 | 225,000 | 562,500 | 525,000 | |
Jan 10 2006 | BLSI | ALSERES PHARMACEUT ... | RICE KENNETH L JR | EVP of Finance and ... | Option Exercise | A | 2.50 | 225,000 | 562,500 | 525,000 | |
Dec 14 2005 | BLSI | ALSERES PHARMACEUT ... | Mullen Michael James | Director | Option Exercise | A | 2.00 | 10,000 | 20,000 | 50,417 | |
Dec 14 2005 | BLSI | ALSERES PHARMACEUT ... | LANGER ROBERT | Director | Option Exercise | A | 2.00 | 10,000 | 20,000 | 89,663 | |
Dec 14 2005 | BLSI | ALSERES PHARMACEUT ... | PRESTON JOHN T | Director | Option Exercise | A | 2.00 | 10,000 | 20,000 | 50,417 | |
Jul 19 2005 | BLSI | ALSERES PHARMACEUT ... | RICE KENNETH L JR | Chief Financial Off ... | Option Exercise | A | 3.25 | 300,000 | 975,000 | 300,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANGER ROBERT | Director | Option Exercise | A | 2.31 | 15,155 | 35,008 | 79,663 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANGER ROBERT | Director | Option Exercise | A | 2.31 | 20,845 | 48,152 | 64,508 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | Chief Scientific Of ... | Option Exercise | A | 2.31 | 134,491 | 310,674 | 192,605 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | Chief Scientific Of ... | Option Exercise | A | 2.31 | 41,114 | 94,973 | 58,114 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | Chief Scientific Of ... | Option Exercise | D | 6.45 | 40,000 | 258,000 | 17,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | Chief Scientific Of ... | Option Exercise | D | 5.00 | 20,000 | 100,000 | 17,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | Chief Scientific Of ... | Option Exercise | D | 9.50 | 25,000 | 237,500 | 17,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | Chief Scientific Of ... | Option Exercise | D | 13.05 | 14,000 | 182,700 | 17,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | Chief Scientific Of ... | Option Exercise | D | 15.62 | 24,000 | 374,880 | 17,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | Chief Scientific Of ... | Option Exercise | D | 16.25 | 22,700 | 368,875 | 17,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | Chief Scientific Of ... | Option Exercise | D | 10.78 | 500 | 5,390 | 17,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | Chief Scientific Of ... | Option Exercise | D | 22.35 | 20,000 | 447,000 | 17,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | Chief Scientific Of ... | Option Exercise | D | 32.81 | 5,000 | 164,050 | 17,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | Chief Scientific Of ... | Option Exercise | D | 39.06 | 15,614 | 609,883 | 17,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | HERNON JOSEPH P | Chief Financial Off ... | Option Exercise | A | 2.31 | 20,000 | 46,200 | 133,527 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | HERNON JOSEPH P | Chief Financial Off ... | Option Exercise | A | 2.31 | 99,527 | 229,907 | 113,527 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | HERNON JOSEPH P | Chief Financial Off ... | Option Exercise | A | 2.31 | 14,000 | 32,340 | 14,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | HERNON JOSEPH P | Chief Financial Off ... | Option Exercise | D | 6.45 | 20,000 | 129,000 | 0 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | HERNON JOSEPH P | Chief Financial Off ... | Option Exercise | D | 5.00 | 15,000 | 75,000 | 0 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | HERNON JOSEPH P | Chief Financial Off ... | Option Exercise | D | 9.50 | 20,000 | 190,000 | 0 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | HERNON JOSEPH P | Chief Financial Off ... | Option Exercise | D | 13.05 | 7,000 | 91,350 | 0 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | HERNON JOSEPH P | Chief Financial Off ... | Option Exercise | D | 15.62 | 18,000 | 281,160 | 0 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | HERNON JOSEPH P | Chief Financial Off ... | Option Exercise | D | 18.12 | 15,000 | 271,800 | 0 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | HERNON JOSEPH P | Chief Financial Off ... | Option Exercise | D | 16.25 | 11,773 | 191,311 | 0 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | HERNON JOSEPH P | Chief Financial Off ... | Option Exercise | D | 22.35 | 9,200 | 205,620 | 0 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | HERNON JOSEPH P | Chief Financial Off ... | Option Exercise | D | 31.50 | 4,800 | 151,200 | 0 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | Mullen Michael James | Director | Option Exercise | A | 2.31 | 15,155 | 35,008 | 40,417 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | Mullen Michael James | Director | Option Exercise | A | 2.31 | 20,262 | 46,805 | 25,262 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | PRESTON JOHN T | Director | Option Exercise | A | 2.31 | 15,155 | 35,008 | 40,417 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | PRESTON JOHN T | Director | Option Exercise | A | 2.31 | 20,262 | 46,805 | 25,262 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | PYKETT MARK JEROME | President | Option Exercise | A | 2.31 | 100,000 | 231,000 | 300,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | SAVAS PETER G | Chief Executive Off ... | Option Exercise | A | 2.31 | 135,529 | 313,072 | 600,000 | |
Mar 15 2005 | BLSI | ALSERES PHARMACEUT ... | SAVAS PETER G | Chief Executive Off ... | Option Exercise | A | 2.31 | 64,471 | 148,928 | 464,471 | |
Feb 08 2005 | BLSI | ALSERES PHARMACEUT ... | PYKETT MARK JEROME | President and COO | Option Exercise | A | 0.75 | 500,000 | 375,000 | 1,000,000 | |
Nov 18 2004 | BLSI | ALSERES PHARMACEUT ... | PYKETT MARK JEROME | EVP & Chief Operati ... | Option Exercise | A | 0.75 | 500,000 | 375,000 | 500,000 | |
Nov 16 2004 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | Option Exercise | J | 1.00 | 500,000 | 500,000 | 500,000 | ||
Nov 16 2004 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | Option Exercise | D | 1.00 | 4,350,000 | 4,350,000 | 0 | ||
Sep 14 2004 | BLSI | ALSERES PHARMACEUT ... | SAVAS PETER G | Chief Executive Off ... | Option Exercise | A | 0.75 | 2,000,000 | 1,500,000 | 2,000,000 | |
Jul 07 2004 | BLSI | ALSERES PHARMACEUT ... | CHRIS PALMER | Option Exercise | X | 0.82 | 7,600 | 6,232 | 0 | ||
Jul 07 2004 | BLSI | ALSERES PHARMACEUT ... | CHRIS PALMER | Buy | X | 0.82 | 7,600 | 6,232 | 54,100 | 46.5 K to 54.1 K (+16.34 %) | |
Jun 17 2004 | BLSI | ALSERES PHARMACEUT ... | HILLSON DAVID | Director | Option Exercise | D | 3.63 | 131,770 | 478,325 | 0 | |
Jun 17 2004 | BLSI | ALSERES PHARMACEUT ... | HILLSON DAVID | Director | Option Exercise | D | 4.47 | 150,000 | 670,500 | 0 | |
Jun 17 2004 | BLSI | ALSERES PHARMACEUT ... | HILLSON DAVID | Director | Option Exercise | D | 6.56 | 25,000 | 164,000 | 0 | |
Jun 17 2004 | BLSI | ALSERES PHARMACEUT ... | HILLSON DAVID | Director | Option Exercise | D | 7.81 | 93,230 | 728,126 | 0 | |
Jun 17 2004 | BLSI | ALSERES PHARMACEUT ... | HILLSON DAVID | Director | Option Exercise | A | 1.00 | 200,000 | 200,000 | 200,000 | |
Jun 17 2004 | BLSI | ALSERES PHARMACEUT ... | PRESTON JOHN T | Director | Option Exercise | A | 1.00 | 25,000 | 25,000 | 25,000 | |
Jun 17 2004 | BLSI | ALSERES PHARMACEUT ... | Mullen Michael James | Director | Option Exercise | A | 1.00 | 25,000 | 25,000 | 25,000 | |
Mar 11 2004 | BLSI | ALSERES PHARMACEUT ... | PECK STEPHEN M | Director | Option Exercise | A | 1.27 | 50,000 | 63,500 | 50,000 | |
Mar 11 2004 | BLSI | ALSERES PHARMACEUT ... | CHRIS PALMER | Director | Option Exercise | A | 1.27 | 65,000 | 82,550 | 65,000 | |
Mar 11 2004 | BLSI | ALSERES PHARMACEUT ... | CHRIS PALMER | Director | Option Exercise | A | 1.27 | 65,000 | 82,550 | 65,000 | |
Mar 11 2004 | BLSI | ALSERES PHARMACEUT ... | LANGER ROBERT | Director | Option Exercise | A | 1.27 | 50,000 | 63,500 | 50,000 | |
Mar 11 2004 | BLSI | ALSERES PHARMACEUT ... | LANGER ROBERT | Director | Option Exercise | A | 1.27 | 50,000 | 63,500 | 50,000 | |
Mar 11 2004 | BLSI | ALSERES PHARMACEUT ... | HILLSON DAVID | Director | Option Exercise | A | 1.27 | 195,000 | 247,650 | 195,000 | |
Mar 11 2004 | BLSI | ALSERES PHARMACEUT ... | BIER COLIN | Director | Option Exercise | A | 1.27 | 180,000 | 228,600 | 180,000 | |
Jan 30 2004 | BLSI | ALSERES PHARMACEUT ... | HERNON JOSEPH P | Executive VP | Option Exercise | A | 1.29 | 100,000 | 129,000 | 100,000 | |
Jan 30 2004 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | President | Option Exercise | A | 1.29 | 200,000 | 258,000 | 200,000 | |
Jan 30 2004 | BLSI | ALSERES PHARMACEUT ... | LANSER MARC | President | Option Exercise | A | 1.29 | 200,000 | 258,000 | 200,000 | |
Sep 30 2003 | BLSI | ALSERES PHARMACEUT ... | GIPSON ROBERT L | 10% Owner | Option Exercise | J | 1.00 | 207,167 | 207,167 | 4,350,500 | |
Sep 30 2003 | BLSI | ALSERES PHARMACEUT ... | BOUCHER THOMAS O JR | 10% Owner | Option Exercise | J | 1.00 | 207,167 | 207,167 | 4,350,000 | |
Sep 30 2003 | BLSI | ALSERES PHARMACEUT ... | INGALLS & SNYDER VALUE PARTNER ... | 10% Owner | Option Exercise | J | 1.00 | 207,167 | 207,167 | 4,350,500 |
Page: 1